We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$283M
AUM Growth
+$191M
Cap. Flow
+$10.3M
Cap. Flow %
3.64%
Top 10 Hldgs %
97.95%
Holding
31
New
8
Increased
5
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
LITS
Lite Strategy Inc
LITS
+$13.5M
2
AMLP icon
Alerian MLP ETF
AMLP
+$4.25M
3
ICMB icon
Investcorp Credit Management BDC
ICMB
+$683K
4
MRKR icon
Marker Therapeutics
MRKR
+$432K
5
KURA icon
Kura Oncology
KURA
+$278K

Top Sells

Rank Stock Value
1
AGRX
Agile Therapeutics
AGRX
+$4.66M
2
SCYX icon
SCYNEXIS
SCYX
+$2.85M
3
FSK icon
FS KKR Capital
FSK
+$508K
4
BUD icon
AB InBev
BUD
+$486K
5
BBDC icon
Barings BDC
BBDC
+$258K

Sector Composition

Rank Sector Weight
1 Miscellaneous 69.64%
2 Healthcare 22.29%
3 Financials 6.85%
4 Real Estate 0.53%
5 Industrials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADNT icon
26
Adient
ADNT
$1.54B
– –
-3,838
Closed -$229K
BUD icon
27
AB InBev
BUD
$158B
– –
-4,425
Closed -$486K
FSK icon
28
FS KKR Capital
FSK
$3.44B
– –
-17,529
Closed -$508K
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$12.5B
– –
-1,999
Closed -$233K
AGRX
30
DELISTED
Agile Therapeutics
AGRX
– –
-907
Closed -$4.66M
DRNA
31
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-13,074
Closed -$125K
1
2

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q2 2018 Portfolio in Review

As of Q2 2018, Caxton Corporation held 31 positions worth $283M, up 207% from $92.1M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Caxton Corporation deployed $10.3M of net new capital in Q2 2018, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Lite Strategy Inc: 220,022 shares worth $17.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, followed by Healthcare and Financials.

On the sell side, the largest reduction was SCYNEXIS, an estimated $2.85M trimmed.

  • Caxton Corporation's largest Q2 2018 buy was Lite Strategy Inc: 220,022 shares worth $17.3M.
  • Caxton Corporation added most to Investcorp Credit Management BDC in Q2 2018, an estimated $683K increase.
  • Caxton Corporation's biggest Q2 2018 reduction was SCYNEXIS, cutting an estimated $2.85M.
  • Caxton Corporation fully exited Agile Therapeutics in Q2 2018, selling an estimated $4.66M.
  • Caxton Corporation's ten largest holdings make up 98% of its $283M portfolio in Q2 2018.
  • Caxton Corporation opened 8 new positions and closed 6 in Q2 2018.
  • Caxton Corporation's portfolio value rose 207% quarter-over-quarter to $283M.

Based on Caxton Corporation's 13F filing for Q2 2018, filed 14 Aug 2018.